FoxHollow founder to take over the helm
This article was originally published in Clinica
Dr John Simpson, the founder of FoxHollow Technologies, is to keep the reins after being appointed permanent CEO of the company. Dr Simpson has been acting as head of the firm on an interim basis after the departure of the previous CEO, Robert Thomas, in January 2006.
You may also be interested in...
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.
Lilly has launched a similar antibody product, but demand is expected to outpace supply for the foreseeable future.